Kidney Program at Forefront of Helping Patients Thrive After Transplants

Hearing that the odds were vastly against her for a successful kidney transplant was not something 29 year-old Rachel Amato wanted to hear from the first doctors she consulted. So what did the mother of four decide to do? She came to Stanford Hospital and Clinics, where she sought out BETTER MEDICINE and an honest answer.

Stanford Hospital & Clinics told Amato, “We have seen proof that this new treatment works. We just don’t know how many doses it’s going to take.”

COMMITTED to FINDING ANSWERS, the desensitization program, as well as improvements in minimally invasive surgery and the promise of an experimental “tolerance induction” protocol, have placed Stanford Hospital & Clinics at the forefront of kidney transplant programs.   Amato was placed in the program in August 2008 and by January 2009 received one more dose of an additional drug and received her transplant two weeks later.

“Even though we’re treating patients at higher risk, we perform better than expected because we have a very good team and our patients get very attentive, individualized care,” said Stephan Busque, MD, surgical director of the adult kidney and pancreas transplant program.

“Stanford was my saving grace because they did not give up on me,” said Amato.

For more information on the desensitization program click here.